1-naphthylamine has been researched along with Central Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corkeron, MA | 1 |
| Cohen, CI; Trappler, B | 1 |
1 trial(s) available for 1-naphthylamine and Central Nervous System Diseases
| Article | Year |
|---|---|
Use of SSRIs in "very old" depressed nursing home residents.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric | 1998 |
1 other study(ies) available for 1-naphthylamine and Central Nervous System Diseases
| Article | Year |
|---|---|
Serotonin syndrome--a potentially fatal complication of antidepressant therapy.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Central Nervous System Diseases; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Tranylcypromine | 1995 |